PE20131037A1 - COMPOSICION INMUNOGENICA QUE COMPRENDE UN CONJUGADO hrEGF-rP64k - Google Patents
COMPOSICION INMUNOGENICA QUE COMPRENDE UN CONJUGADO hrEGF-rP64kInfo
- Publication number
- PE20131037A1 PE20131037A1 PE2013000227A PE2013000227A PE20131037A1 PE 20131037 A1 PE20131037 A1 PE 20131037A1 PE 2013000227 A PE2013000227 A PE 2013000227A PE 2013000227 A PE2013000227 A PE 2013000227A PE 20131037 A1 PE20131037 A1 PE 20131037A1
- Authority
- PE
- Peru
- Prior art keywords
- hregf
- rp64k
- immunogenic composition
- composition including
- conjugate
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- GZCGUPFRVQAUEE-KVTDHHQDSA-N aldehydo-D-mannose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O GZCGUPFRVQAUEE-KVTDHHQDSA-N 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000021615 conjugation Effects 0.000 abstract 1
- 238000011026 diafiltration Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002480 mineral oil Substances 0.000 abstract 1
- 235000010446 mineral oil Nutrition 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000000108 ultra-filtration Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00113—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
REFERIDA A UNA COMPOSICION DE VACUNA QUE COMPRENDE UN CONJUGADO PROTEICO hrEGF-rP64k Y COMO ADYUVANTES UN ACEITE MINERAL PURIFICADO Y MONOOLEATO DE MANOSA, DONDE LA RAZON DE CONJUGACION ENTRE LA PROTEINA rP64k Y EL hregf ES DE 12,04:24,05 NMOLAR. TAMBIEN ESTA REFERIDA A UN PROCEDIMIENTO DE PREPARACION, EL CUAL INCLUYE UN PASO DE PURIFICACION REALIZADO MEDIANTE ULTRAFILTRACION/DIAFILTRACION. DICHA COMPOSICION ES UTIL EN EL TRATAMIENTO DEL CANCER
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20070154A CU23652A1 (es) | 2007-06-29 | 2007-06-29 | Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención |
| PCT/CU2008/000005 WO2009003425A1 (es) | 2007-06-29 | 2008-06-26 | Obtención de un preparado vacunal homogéneo para el tratamiento del cáncer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20131037A1 true PE20131037A1 (es) | 2013-10-07 |
Family
ID=40225717
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001089A PE20090426A1 (es) | 2007-06-29 | 2008-06-26 | Composicion vacunal homogenea para el tratamiento del cancer y su metodo de obtencion |
| PE2013000227A PE20131037A1 (es) | 2007-06-29 | 2008-06-26 | COMPOSICION INMUNOGENICA QUE COMPRENDE UN CONJUGADO hrEGF-rP64k |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2008001089A PE20090426A1 (es) | 2007-06-29 | 2008-06-26 | Composicion vacunal homogenea para el tratamiento del cancer y su metodo de obtencion |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US8778879B2 (es) |
| EP (1) | EP2184072B1 (es) |
| JP (1) | JP5368437B2 (es) |
| KR (1) | KR20100039372A (es) |
| CN (1) | CN101790383B (es) |
| AR (1) | AR067085A1 (es) |
| AT (1) | ATE536885T1 (es) |
| AU (1) | AU2008271798B2 (es) |
| BR (1) | BRPI0813662B8 (es) |
| CA (1) | CA2692340C (es) |
| CL (1) | CL2008001936A1 (es) |
| CO (1) | CO6251274A2 (es) |
| CU (1) | CU23652A1 (es) |
| CY (1) | CY1112476T1 (es) |
| DK (1) | DK2184072T3 (es) |
| EA (1) | EA021905B1 (es) |
| ES (1) | ES2379130T3 (es) |
| HR (1) | HRP20120218T1 (es) |
| JO (1) | JO2777B1 (es) |
| MY (1) | MY149136A (es) |
| NZ (1) | NZ582829A (es) |
| PE (2) | PE20090426A1 (es) |
| PL (1) | PL2184072T3 (es) |
| PT (1) | PT2184072E (es) |
| RS (1) | RS52196B (es) |
| SI (1) | SI2184072T1 (es) |
| TW (1) | TWI409080B (es) |
| UY (1) | UY31184A1 (es) |
| WO (1) | WO2009003425A1 (es) |
| ZA (1) | ZA201000609B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU20200032A7 (es) * | 2020-06-09 | 2022-01-13 | Ct Inmunologia Molecular | Composiciones vacunales basadas en nano-partículas de fosfatos de calcio para el tratamiento del cáncer |
| CN114594257B (zh) * | 2022-05-09 | 2022-08-05 | 北京生物制品研究所有限责任公司 | 含CpG ODN的吸附型疫苗的解吸附组合物及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2261433A1 (en) * | 1993-12-09 | 1995-06-10 | Belinda Sanchez Ramirez | Composition comprising autologous epidermal growth factor |
| CA2137639C (en) | 1993-12-09 | 1999-01-26 | Agustin B. L. Davila | Vaccine composition comprising autologous epidermal growth factor or a fragment or a derivate thereof having anti-tumor activity and use thereof in the therapy of malignant diseases |
| CU23077A1 (es) * | 2000-12-06 | 2005-08-17 | Centro Inmunologia Molecular | Composicion vacunal que contiene factor de crecimiento transformante (tgf-alfa). su uso en la terapia de enfermedades malignas |
| CU22979A1 (es) * | 2000-12-08 | 2004-09-09 | Centro Inmunologia Molecular | Combinación inmunoterapéutica para el tratamiento de tumores que sobre-expresan receptores con actividad quinasa en residuos de tirosina |
| GB0109297D0 (en) * | 2001-04-12 | 2001-05-30 | Glaxosmithkline Biolog Sa | Vaccine |
| CU22999A1 (es) * | 2001-12-04 | 2004-10-12 | Centro Inmunologia Molecular | Método de tratamiento de enfermedades malignas e infecciosas crónicas |
| FR2844514B1 (fr) * | 2002-09-16 | 2007-10-19 | Neovacs | Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation |
| GB0405787D0 (en) * | 2004-03-15 | 2004-04-21 | Chiron Srl | Low dose vaccines |
-
2007
- 2007-06-29 CU CU20070154A patent/CU23652A1/es unknown
-
2008
- 2008-06-20 AR ARP080102638A patent/AR067085A1/es not_active Application Discontinuation
- 2008-06-26 HR HR20120218T patent/HRP20120218T1/hr unknown
- 2008-06-26 AU AU2008271798A patent/AU2008271798B2/en active Active
- 2008-06-26 TW TW097123928A patent/TWI409080B/zh active
- 2008-06-26 KR KR1020107002173A patent/KR20100039372A/ko not_active Ceased
- 2008-06-26 US US12/664,545 patent/US8778879B2/en active Active
- 2008-06-26 EP EP08757902A patent/EP2184072B1/en active Active
- 2008-06-26 PE PE2008001089A patent/PE20090426A1/es not_active Application Discontinuation
- 2008-06-26 BR BRPI0813662A patent/BRPI0813662B8/pt active IP Right Grant
- 2008-06-26 AT AT08757902T patent/ATE536885T1/de active
- 2008-06-26 PE PE2013000227A patent/PE20131037A1/es not_active Application Discontinuation
- 2008-06-26 PL PL08757902T patent/PL2184072T3/pl unknown
- 2008-06-26 JP JP2010513634A patent/JP5368437B2/ja active Active
- 2008-06-26 PT PT08757902T patent/PT2184072E/pt unknown
- 2008-06-26 NZ NZ582829A patent/NZ582829A/en active IP Right Revival
- 2008-06-26 DK DK08757902.5T patent/DK2184072T3/da active
- 2008-06-26 CA CA2692340A patent/CA2692340C/en active Active
- 2008-06-26 UY UY31184A patent/UY31184A1/es unknown
- 2008-06-26 WO PCT/CU2008/000005 patent/WO2009003425A1/es not_active Ceased
- 2008-06-26 MY MYPI20095626A patent/MY149136A/en unknown
- 2008-06-26 SI SI200830563T patent/SI2184072T1/sl unknown
- 2008-06-26 RS RS20120101A patent/RS52196B/sr unknown
- 2008-06-26 EA EA201070080A patent/EA021905B1/ru not_active IP Right Cessation
- 2008-06-26 ES ES08757902T patent/ES2379130T3/es active Active
- 2008-06-26 CN CN200880021856XA patent/CN101790383B/zh active Active
- 2008-06-27 CL CL2008001936A patent/CL2008001936A1/es unknown
- 2008-06-29 JO JO2008307A patent/JO2777B1/en active
-
2009
- 2009-12-18 CO CO09145155A patent/CO6251274A2/es active IP Right Grant
-
2010
- 2010-01-27 ZA ZA201000609A patent/ZA201000609B/xx unknown
-
2012
- 2012-01-10 US US13/346,831 patent/US8841251B2/en active Active
- 2012-03-09 CY CY20121100245T patent/CY1112476T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02736A (es) | ||
| MX375202B (es) | Composiciones adyuvantes novedosas. | |
| ECSP088504A (es) | Uso de flibanserina para el tratamiento de trastornos del deseo sexual premenopáusicos | |
| MX341395B (es) | Compuestos (lipopeptidos basados en cisteina) y composiciones como agonistas de tlr2 usados para el tratamiento de infecciones, inflamaciones, enfermedades respiratorias, etc. | |
| CY1120413T1 (el) | Ειδικα εξανθρωπισμενα αντισωματα στην πρωτοϊνιδιακη μορφη του βητα-αμυλοειδους πεπτιδιου | |
| EA201001639A1 (ru) | Композиции и способы их получения и применения | |
| PE20091352A1 (es) | Composicion que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes acidas | |
| EA200970471A1 (ru) | Микроорганизмы или их фракции, обеспечивающие активацию клеточного иммунитета против углеводов | |
| PH12013502192A1 (en) | Antibodies against human angiopoietin 2 | |
| EA201491819A1 (ru) | Фармацевтические композиции для комбинированного лечения | |
| HK1203309A1 (zh) | 抗體-藥物綴合物以及相關化合物、組合物和方法 | |
| UA118332C2 (uk) | Білок, що зв'язує антиген cd27l | |
| EA200970581A1 (ru) | Кристаллическое твёрдое основание разагилина | |
| MY157661A (en) | Bendamustine pharmaceutical compositions | |
| MA32161B1 (fr) | Formes de rifaximine et utilisations de celles-ci | |
| EA201270356A1 (ru) | Иммуногенные композиции, содержащие модуляторы активности tlr | |
| PE20110065A1 (es) | Composiciones y metodos para preparar composiciones inmunogenicas de conjugado de polisacarido capsular de staphylococcus aureus serotipos 5 y 8 | |
| BR112015020389A2 (pt) | compostos carbazol úteis como inibidores de bromodomínio | |
| PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
| ECSP045069A (es) | Uso de flibanserina en el tratamiento de trastornos sexuales | |
| MY157473A (en) | Antibody molecules having specificity for human ox40 | |
| PE20142115A1 (es) | Composiciones de neisseria meningitidis y metodos de las mismas | |
| IN2012DN02645A (es) | ||
| PL2228374T3 (pl) | Mrówczan nebiwololu | |
| TW200728466A (en) | Antibody molecules having specificity for human IL-6 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |